Edgar M Espana1, Mei Sun2, David E Birk2. 1. Department of Molecular Pharmacology & Physiology Morsani College of Medicine, University of South Florida, Tampa, Florida, United States 2Department of Ophthalmology, Morsani College of Medicine, University of South Florida, Tampa, Florida, United States. 2. Department of Molecular Pharmacology & Physiology Morsani College of Medicine, University of South Florida, Tampa, Florida, United States.
Abstract
PURPOSE: To demonstrate the presence and location of corneal endothelial progenitor cells. METHODS: Progenitor cell markers nestin, leucine-rich repeat-containing G-protein-coupled receptor 5, Sox9, and nerve growth factor receptor p75, as well as proliferation marker Ki-67, were examined on postnatal day (P)3, P30, and P90 corneas using immunofluorescence microscopy. Mice (P3) were pulsed with 5-bromo-2'-deoxyuridine (BrdU) and chased. RESULTS: Cell proliferation was observed in all layers of P3 corneas. No posterior stromal cell proliferation was noted in P30 corneas. Progenitor cell markers were expressed in the P3 cornea, but were downregulated during maturation with minimal or no expression in P90 central corneas. In contrast, cells expressing progenitor markers were located exclusively at the corneal periphery at P90. Clusters of cells reactive for progenitor markers were in the endothelial and subendothelial space in the P90 peripheral cornea. Reactivity against BrdU was localized to the central and peripheral cornea at 1 week, and to the extreme periphery 3 weeks following a BrdU pulse. Cells reactive for both BrdU and progenitor markers were localized to the peripheral endothelium. At 3 weeks, cells reactive for BrdU and the progenitor markers were localized in the peripheral endothelium. Approximately, 20% to 45% of the progenitor marker positive cells also were labeled with BrdU. CONCLUSIONS: During development, the murine corneal endothelium is composed of proliferating cells expressing progenitor markers. In contrast, in the mature endothelium slow-cycling cells, cells expressing progenitor markers and a subpopulation of slow-cycling cells expressing progenitor makers are restricted to the endothelial periphery.
PURPOSE: To demonstrate the presence and location of corneal endothelial progenitor cells. METHODS: Progenitor cell markers nestin, leucine-rich repeat-containing G-protein-coupled receptor 5, Sox9, and nerve growth factor receptor p75, as well as proliferation marker Ki-67, were examined on postnatal day (P)3, P30, and P90 corneas using immunofluorescence microscopy. Mice (P3) were pulsed with 5-bromo-2'-deoxyuridine (BrdU) and chased. RESULTS: Cell proliferation was observed in all layers of P3 corneas. No posterior stromal cell proliferation was noted in P30 corneas. Progenitor cell markers were expressed in the P3 cornea, but were downregulated during maturation with minimal or no expression in P90 central corneas. In contrast, cells expressing progenitor markers were located exclusively at the corneal periphery at P90. Clusters of cells reactive for progenitor markers were in the endothelial and subendothelial space in the P90 peripheral cornea. Reactivity against BrdU was localized to the central and peripheral cornea at 1 week, and to the extreme periphery 3 weeks following a BrdU pulse. Cells reactive for both BrdU and progenitor markers were localized to the peripheral endothelium. At 3 weeks, cells reactive for BrdU and the progenitor markers were localized in the peripheral endothelium. Approximately, 20% to 45% of the progenitor marker positive cells also were labeled with BrdU. CONCLUSIONS: During development, the murine corneal endothelium is composed of proliferating cells expressing progenitor markers. In contrast, in the mature endothelium slow-cycling cells, cells expressing progenitor markers and a subpopulation of slow-cycling cells expressing progenitor makers are restricted to the endothelial periphery.
Authors: C Claus Stolt; Petra Lommes; Elisabeth Sock; Marie-Christine Chaboissier; Andreas Schedl; Michael Wegner Journal: Genes Dev Date: 2003-07-01 Impact factor: 11.361
Authors: Marc van de Wetering; Elena Sancho; Cornelis Verweij; Wim de Lau; Irma Oving; Adam Hurlstone; Karin van der Horn; Eduard Batlle; Damien Coudreuse; Anna Pavlina Haramis; Menno Tjon-Pon-Fong; Petra Moerer; Maaike van den Born; Gwen Soete; Steven Pals; Martin Eilers; Rene Medema; Hans Clevers Journal: Cell Date: 2002-10-18 Impact factor: 41.582
Authors: James W Foster; Karl Wahlin; Sheila M Adams; David E Birk; Donald J Zack; Shukti Chakravarti Journal: Sci Rep Date: 2017-01-27 Impact factor: 4.379
Authors: Bruce A Corliss; H Clifton Ray; Corbin Mathews; Kathleen Fitzgerald; Richard W Doty; Chris M Smolko; Hamzah Shariff; Shayn M Peirce; Paul A Yates Journal: Invest Ophthalmol Vis Sci Date: 2019-12-02 Impact factor: 4.799
Authors: David Eveleth; Sarah Pizzuto; Jessica Weant; Jennifer Jenkins-Eveleth; Ralph A Bradshaw Journal: J Ocul Pharmacol Ther Date: 2020-07-28 Impact factor: 2.671